Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,930
-$138,311 QoQ
Shares Held
500
-66.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,157
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $190,507 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
4,649 | $74,523 | |
| 2 | VTRS |
Viatris Inc
|
4,478 | $71,110 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
500 | $35,930 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
119 | $2,928 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4 | $2,167 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11 | $1,853 | |
| 7 | ALKS |
Alkermes plc.
|
20 | $1,048 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
28 | $948 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,930 | 500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $174,241 | 1,474 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $207,854 | 1,652 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $209,237 | 1,430 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $239,383 | 1,535 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $393,678 | 2,391 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $393,313 | 2,414 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $464,027 | 2,375 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $396,127 | 2,285 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $380,045 | 2,246 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $392,963 | 1,991 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $316,643 | 1,820 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $309,805 | 1,799 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $256,484 | 1,541 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $200,187 | 1,366 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $9,935 | 67 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $10,657 | 62 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $13,955 | 74 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $22,450 | 92 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $233,550 | 1,203 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $205,182 | 1,101 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $166,141 | 1,055 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $179,236 | 1,083 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $168,842 | 1,021 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $139,095 | 1,015 | Shares | Sole | 2020-09-28 | |
| 2020-03-31 | $119,455 | 1,015 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||